N-(3-(5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide-D7; N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide-D7; PLX 4032-D7; RG 7204-D7; Ro 51-85426-D7;
Vemurafenib-d7 is a fully characterized chemical compound used as a reference standard of API Vemurafenib. The standard offered is compliant with regulatory guidelines. Vemurafenib-d7 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1365986-73-7
